🔎 Trials Near Me

홈 › 두경부암 › 플로리다

플로리다의 두경부암 임상 시험

두경부암 관련 연구 25개가 플로리다 내 여러 지역에서 참여자를 모집하고 있습니다.

플로리다의 도시

공식 연구 텍스트(영어)

A Study to Evaluate Lenti-HPV-07 Immunotherapy Against HPV+ Cervical or Oropharyngeal Cancer

  • Florida Cancer Specialists (from Sarah Canon research Institute), Orlando
  • Tampa General Hospital, Tampa
  • Moffitt Cancer Center, Tampa
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 11. 10. 업데이트됨 · NCT06319963

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

  • Clermont Oncology Center, Clermont
  • Mid Florida Hematology and Oncology Center, Orange City
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 11. 6. 업데이트됨 · NCT04198766

VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma

  • Holy Cross Hospital (site 213), Fort Lauderdale
  • Memorial Cancer Institute at Memorial Healthcare Systems (site 132), Pembroke Pines
피험자 모집 중1/2상
18세 ~ 80세 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT03556228

FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC

  • Mayo Clinic Florida (Site #0148), Jacksonville
  • Cancer Care Centers of Brevard (Site #0136), Palm Bay
  • Moffit Cancer Center (Site #0105), Tampa
피험자 모집 중2/3상
18세 이상 · 모든 성별 · 2026. 10. 29. 업데이트됨 · NCT06788990

Ordastobart (INBRX-106) Add-on to Pembrolizumab in 1L HPV+ PD-L1+ R/M OPSCC (HexAgon-HN)

  • The Oncology Institute of Hope & Innovation, Miami
  • Mid Florida Hematology and Oncology Center, Orange City
피험자 모집 중2/3상
18세 이상 · 모든 성별 · 2026. 10. 28. 업데이트됨 · NCT06295731

Lead-212 PSV359 Therapy for Patients With Solid Tumors

  • University of Miami, Miami
  • Biogenix, Miami
피험자 모집 중1/2상
18세 ~ 90세 · 모든 성별 · 2026. 10. 28. 업데이트됨 · NCT06710756

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

  • AdventHealth Medical Group Oncology Research at Celebration, Kissimmee
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 10. 26. 업데이트됨 · NCT06172478

Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors

  • Sylvester Comprehensive Cancer Center - University of Miami Health System, Miami
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 10. 15. 업데이트됨 · NCT06239194

A Study Evaluating Ficerafusp Alfa (BCA101) QW in Combination With Pembrolizumab vs Alternative Ficerafusp Alfa Dosing in 1L R or M HNSCC

  • Site US077, Fort Myers
  • Site US078, Orlando
  • Site US075, St. Petersburg
  • 외 1개
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 10. 13. 업데이트됨 · NCT07807163

Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors

  • H. Lee Moffitt Cancer Center and Research Institute, Inc, Tampa
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 10. 6. 업데이트됨 · NCT04429542

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

  • University of Miami - Sylvester Comprehensive Cancer Center, Miami
  • Advent Health, Orlando
  • Florida Cancer Specialists South, Port Charlotte
피험자 모집 중1/2상
12세 이상 · 모든 성별 · 2026. 10. 2. 업데이트됨 · NCT04585750

A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors

  • ALX Center 7, Tampa
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 30. 업데이트됨 · NCT07085091

DESTINY-PANTUMOUR04

  • Research Site, Coral Springs
  • Research Site, St. Petersburg
  • Research Site, West Palm Beach
피험자 모집 중관찰 연구
18세 ~ 130세 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT07124000

A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors

  • Biogenix Molecular, LLC, Miami
  • Advent Health Medical Group Radiation Oncology at Central Florida, Orlando
  • Moffitt Cancer Center, Tampa
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 17. 업데이트됨 · NCT07020117

First in Human Study of TUB-030 in Patients With Advanced Solid Tumors

  • University of Miami, Miami
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 9. 11. 업데이트됨 · NCT06657222

Prehabilitation Protocol for Head and Neck Cancer Patients

  • University of Miami, Miami
피험자 모집 중건강한 지원자 환영
18세 ~ 80세 · 모든 성별 · 2026. 9. 1. 업데이트됨 · NCT07318220

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

  • AdventHealth Celebration, Celebration
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 8. 11. 업데이트됨 · NCT05592626

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

  • Moffitt Cancer Center, Tampa
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 7. 7. 업데이트됨 · NCT05768139

MEM-288 Oncolytic Virus Alone and in Combination With Standard of Care Therapy in Advanced Solid Tumors

  • Moffitt Cancer Center, Tampa
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 6. 11. 업데이트됨 · NCT05076760

A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

  • Memorial Healthcare System, Hollywood
피험자 모집 중1/2상
12세 이상 · 모든 성별 · 2026. 5. 27. 업데이트됨 · NCT03093116

A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma

  • GSK Investigational Site, St. Petersburg
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 5. 26. 업데이트됨 · NCT06256588

PromotinG Lung Cancer screenIng Awareness and Implementation in Hispanics/Latinx Head and Neck canceR Survivors

  • University of Miami, Miami
피험자 모집 중
18세 ~ 80세 · 모든 성별 · 2026. 4. 28. 업데이트됨 · NCT06124508

Phase 2 Trial of Adaptive Radiotherapy Boost for HNSCC

  • Moffitt Cancer Center, Tampa
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 4. 1. 업데이트됨 · NCT06137274

HPV DNA-Guided Radiotherapy De-intensification of Head and Neck Squamous Cell Carcinoma

  • Miami Cancer Institute, Miami
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 2. 5. 업데이트됨 · NCT05962242

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Jacksonville
  • Massive Bio SYNERGY-AI site, Miami
  • Massive Bio SYNERGY-AI site, Tampa
피험자 모집 중관찰 연구
전 연령 · 모든 성별 · 2025. 10. 28. 업데이트됨 · NCT03452774

ClinicalTrials.gov 출처, 2026. 11. 15. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.